Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 and DLI after Chemotherapy for Relapsed Leukemia
NCT00005802Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 1999
- Primary completion
- Mar 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Fred Hutchinson Cancer Center. Started Jun 1999; status: completed.
02
Drugs
aldesleukin
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00005802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005802.